NAS:NGM (N/A) Also trade in: Germany

NGM Biopharmaceuticals Inc

$ 13.85 0.05 (0.36%)
Volume: 101,052 Avg Vol (1m): 70,576
Market Cap $: 914.40 Mil Enterprise Value $: 707.77 Mil
P/E (TTM): 0.00 P/B: 3.99
Earnings Power Value 0
Net Current Asset Value 2.9
Tangible Book 3.48
Projected FCF 0
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
100.00% of 1078 companies
in the Biotechnology industry.
Industry Max: 20856.43, Med: 64.02, Min: 0.01
NGM: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
N/A
Equity-to-Asset 0.76
Equity-to-Asset ranked higher than
100.00% of 763 companies
in the Biotechnology industry.
Industry Max: 3.47, Med: 0.69, Min: -9.46
NGM: 0.76
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.49, Med: -0.42, Max: 0.76
Current: 0.76
-0.49
0.76
Interest Coverage No Debt
Interest Coverage ranked higher than
100.00% of 500 companies
in the Biotechnology industry.
Industry Max: 22756408, Med: 10000, Min: 0.12
NGM: No Debt
Ranked among companies with meaningful Interest Coverage only.
N/A
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.23
DISTRESS
GREY
SAFE
Beneish M-Score -2.35
Not Manipulator
Manipulator

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -3.97
Operating Margin ranked higher than
100.00% of 792 companies
in the Biotechnology industry.
Industry Max: 46829238.82, Med: -113.97, Min: -1969600
NGM: -3.97
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -22.59, Med: -9.77, Max: -3.97
Current: -3.97
-22.59
-3.97
Net Margin % -0.45
Net Margin ranked higher than
100.00% of 792 companies
in the Biotechnology industry.
Industry Max: 49899604.52, Med: -111.91, Min: -2150400
NGM: -0.45
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -18.35, Med: -8.09, Max: -0.45
Current: -0.45
-18.35
-0.45
ROE % -1.50
ROE ranked higher than
100.00% of 989 companies
in the Biotechnology industry.
Industry Max: 326.78, Med: -42.82, Min: -100794.12
NGM: -1.5
Ranked among companies with meaningful ROE only.
N/A
ROA % -0.20
ROA ranked higher than
100.00% of 1084 companies
in the Biotechnology industry.
Industry Max: 224.74, Med: -34.77, Min: -3751.92
NGM: -0.2
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -5.38, Med: -2.5, Max: -0.2
Current: -0.2
-5.38
-0.2
ROC (Joel Greenblatt) % -17.14
ROC (Joel Greenblatt) ranked higher than
100.00% of 1036 companies
in the Biotechnology industry.
Industry Max: 641137.84, Med: -521.46, Min: -3427023.81
NGM: -17.14
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -66.93, Med: -30.75, Max: -17.14
Current: -17.14
-66.93
-17.14

» NGM's 30-Y Financials

Financials (Next Earnings Date: 2019-08-15)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:NGM

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325414    SIC : 2836
Compare
Traded in other countries 0IK.Germany
Address

Ratios

Current vs industry vs history
PB Ratio 3.99
PB Ratio ranked higher than
100.00% of 962 companies
in the Biotechnology industry.
Industry Max: 2236, Med: 4.1, Min: 0.05
NGM: 3.99
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0, Med: 0, Max: 6.42
Current: 3.99
0
6.42
PS Ratio 6.82
PS Ratio ranked higher than
100.00% of 726 companies
in the Biotechnology industry.
Industry Max: 113071.43, Med: 9999, Min: 0.01
NGM: 6.82
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0, Med: 0, Max: 6.94
Current: 6.82
0
6.94
EV-to-EBIT -164.06
EV-to-EBIT ranked higher than
100.00% of 261 companies
in the Biotechnology industry.
Industry Max: 4391.42, Med: 22.17, Min: 0.02
NGM: -164.06
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -230.22, Med: 0, Max: 0
Current: -164.06
-230.22
0
EV-to-EBITDA 243.33
EV-to-EBITDA ranked higher than
100.00% of 281 companies
in the Biotechnology industry.
Industry Max: 28816.43, Med: 18.08, Min: 0.02
NGM: 243.33
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 0, Med: 0, Max: 341.4
Current: 243.33
0
341.4
EV-to-Revenue 6.50
EV-to-Revenue ranked higher than
100.00% of 771 companies
in the Biotechnology industry.
Industry Max: 118933, Med: 13.69, Min: 0.05
NGM: 6.5
Ranked among companies with meaningful EV-to-Revenue only.
N/A
Current Ratio 5.17
Current Ratio ranked higher than
100.00% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.46, Min: 0.01
NGM: 5.17
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 4.76, Med: 5.17, Max: 6.23
Current: 5.17
4.76
6.23
Quick Ratio 5.17
Quick Ratio ranked higher than
100.00% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.18, Min: 0.01
NGM: 5.17
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 4.76, Med: 5.17, Max: 6.23
Current: 5.17
4.76
6.23

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 3.98
Price-to-Tangible-Book ranked higher than
100.00% of 894 companies
in the Biotechnology industry.
Industry Max: 800, Med: 5.32, Min: 0.05
NGM: 3.98
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 0, Med: 0, Max: 4.05
Current: 3.98
0
4.05
Earnings Yield (Joel Greenblatt) % -0.59
Earnings Yield (Greenblatt) ranked higher than
100.00% of 1081 companies
in the Biotechnology industry.
Industry Max: 5000, Med: -7.73, Min: -10000
NGM: -0.59
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -0.69, Med: 0, Max: 0
Current: -0.59
-0.69
0

More Statistics

Revenue (TTM) (Mil) $ 108.67
EPS (TTM) $ -0.01
Beta 0
Volatility % 0
52-Week Range $ 12 - 18.75
Shares Outstanding (Mil) 66.02

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y